Skip to content

CROI: New NNRTI, TMC278, demonstrates sustained potency, better CNS and lipid profile than efavirenz, in treatment-naive

CROI: Haiti is the source of HIV subtype B

CROI: Rate of CD4 decline is a poor guide to the risk of AIDS, say investigators

CROI: Once daily Kaletra may be less effective when viral load above 100,000 copies/ml

CROI: Recent OIs or AIDS strongest predictors of development of resistance in South African first-line failures

CROI: Further evidence that short-course PMTCT prophylaxis compromises mother's future treatment

CROI: Sexual transmission of HCV not limited to HIV-positive gay men

CROI: Effects of transmitted drug resistance on viral load are drug class specific

CROI: Ugandan study confirms low CD4 count, low body weight, TB and anaemia major risk factors for death after starting ART